Neglected No More: Emerging Cellular Therapies in Traumatic Injury

Lacy E. Lowry, Maryanne C. Herzig, Barbara A. Christy, Richard Schäfer, Shibani Pati, Andrew P. Cap, James A. Bynum

Resultado de la investigación: Review articlerevisión exhaustiva

1 Cita (Scopus)


Traumatic injuries are a leading cause of death and disability in both military and civilian populations. Given the complexity and diversity of traumatic injuries, novel and individualized treatment strategies are required to optimize outcomes. Cellular therapies have potential benefit for the treatment of acute or chronic injuries, and various cell-based pharmaceuticals are currently being tested in preclinical studies or in clinical trials. Cellular therapeutics may have the ability to complement existing therapies, especially in restoring organ function lost due to tissue disruption, prolonged hypoxia or inflammatory damage. In this article we highlight the current status and discuss future directions of cellular therapies for the treatment of traumatic injury. Both published research and ongoing clinical trials are discussed here. Graphical abstract: [Figure not available: see fulltext.]

Idioma originalEnglish (US)
Páginas (desde-hasta)1194-1214
Número de páginas21
PublicaciónStem Cell Reviews and Reports
EstadoPublished - ago 2021
Publicado de forma externa

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research


Profundice en los temas de investigación de 'Neglected No More: Emerging Cellular Therapies in Traumatic Injury'. En conjunto forman una huella única.

Citar esto